Last reviewed · How we verify

NCT04182035

The Effectiveness of Patient-tailored Treatment in Patients With (Sub)Acute Neck Pain

Completed NA Last updated 29 April 2024
What this trial tests

NA trial testing patient-tailored therapy in Neck Pain in 61 participants. Completed in 31 January 2024.

Timeline
1 December 2019
Primary endpoint
31 January 2024
31 January 2024

Quick facts

Lead sponsorUniversity Ghent
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingdouble
Primary purposetreatment
Enrollment61
Start date1 December 2019
Primary completion31 January 2024
Estimated completion31 January 2024
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

University Ghent

Who can join

Adults 18 to 65, any sex, with Neck Pain or Acute Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the present study is to examine if a patient-tailored treatment program has a better effect on pain and disability than a non-patient tailored treatment or wait and see approach in patients with (sub)acute (recurrent) NSNP. A secondary goal is to evaluate the global perceived effect, treatment adherence, recurrence, work absenteeism and medication use. All interventional treatment arms will consist of a treatment part in a clinical practice setting, under supervision of a trained physiotherapist, and an educational intervention and will be compared to the control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Neck Pain

Currently open trials in the same condition.

Other University Ghent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04182035.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing